Cargando…
A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors
Strategies to target nanoparticles to tumors that rely on surface modification with ligands that bind molecules overexpressed on cancer cells or the tumor neovasculature suffer from a major limitation: with delivery of toxic agents the amount of molecules available for targeting decreases with time;...
Autores principales: | Chen, Zeming, Patel, Jaymin M., Noble, Philip W., Garcia, Cesar, Hong, Zhangyong, Hansen, James E., Zhou, Jiangbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312362/ https://www.ncbi.nlm.nih.gov/pubmed/27494868 http://dx.doi.org/10.18632/oncotarget.11015 |
Ejemplares similares
-
DNA-dependent targeting of cell nuclei by a lupus autoantibody
por: Weisbart, Richard H., et al.
Publicado: (2015) -
BSCI-04. TARGETING TRIPLE-NEGATIVE BREAST CANCER BRAIN METASTASES WITH A RE-ENGINEERED LUPUS AUTOANTIBODY
por: Zhang, Shenqi, et al.
Publicado: (2019) -
A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells
por: Noble, Philip W., et al.
Publicado: (2014) -
Autocatalytic sets and boundaries
por: Hordijk, Wim, et al.
Publicado: (2015) -
Autocatalytic flow chemistry
por: Galanics, Csenge, et al.
Publicado: (2023)